<?xml version="1.0" encoding="UTF-8"?>
<html lang="en" dir="ltr" xmlns="http://www.w3.org/1999/xhtml">
 <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#"> 
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> 
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes"/> 
  <meta name="type" content="article"/>
  <meta name="HW.identifier" content="/biorxiv/early/2020/04/12/2020.04.07.030742.atom"/>
  <meta name="HW.pisa" content="biorxiv;2020.04.07.030742v2"/>
  <meta name="DC.Format" content="text/html"/>
  <meta name="DC.Language" content="en"/>
  <meta name="DC.Title" content="Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue"/>
  <meta name="DC.Identifier" content="10.1101/2020.04.07.030742"/>
  <meta name="DC.Date" content="2020-04-12"/>
  <meta name="DC.Publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="DC.Rights" content="Â© 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NoDerivs 4.0 International), CC BY-ND 4.0, as described at http://creativecommons.org/licenses/by-nd/4.0/"/>
  <meta name="DC.AccessRights" content="restricted"/>
  <meta name="DC.Description" content="In December 2019, SARS-CoV-2 emerged causing the COVID-19 pandemic. SARS-CoV, the agent responsible for the 2003 SARS outbreak, utilizes ACE2 and TMPRSS2 host molecules for viral entry. ACE2 and TMPRSS2 have recently been implicated in SARS-CoV-2 viral infection. Additional host molecules including ADAM17, cathepsin L, CD147, and GRP78 may also function as receptors for SARS-CoV-2. To determine the expression and in situ localization of candidate SARS-CoV-2 receptors in the respiratory mucosa, we analyzed gene expression datasets from airway epithelial cells of 515 healthy subjects, gene promoter activity analysis using the FANTOM5 dataset containing 120 distinct sample types, single cell RNA sequencing (scRNAseq) of 10 healthy subjects, immunoblots on multiple airway epithelial cell types, and immunohistochemistry on 98 human lung samples. We demonstrate absent to low ACE2 promoter activity in a variety of lung epithelial cell samples and low ACE2 gene expression in both microarray and scRNAseq datasets of epithelial cell populations. Consistent with gene expression, rare ACE2 protein expression was observed in the airway epithelium and alveoli of human lung. We present confirmatory evidence for the presence of TMPRSS2, CD147, and GRP78 protein in vitro in airway epithelial cells and confirm broad in situ protein expression of CD147 in the respiratory mucosa. Collectively, our data suggest the presence of a mechanism dynamically regulating ACE2 expression in human lung, perhaps in periods of SARS-CoV-2 infection, and also suggest that alternate receptors for SARS-CoV-2 exist to facilitate initial host cell infection. ### Competing Interest Statement The authors have declared no competing interest."/>
  <meta name="DC.Contributor" content="Jennifer A Aguiar"/>
  <meta name="DC.Contributor" content="Benjamin Jean-Marie Tremblay"/>
  <meta name="DC.Contributor" content="Michael J Mansfield"/>
  <meta name="DC.Contributor" content="Owen Woody"/>
  <meta name="DC.Contributor" content="Briallen Lobb"/>
  <meta name="DC.Contributor" content="Arinjay Banerjee"/>
  <meta name="DC.Contributor" content="Abiram Chandiramohan"/>
  <meta name="DC.Contributor" content="Nicholas Tiessen"/>
  <meta name="DC.Contributor" content="Anna Dvorkin-Gheva"/>
  <meta name="DC.Contributor" content="Spencer Revill"/>
  <meta name="DC.Contributor" content="Matthew S Miller"/>
  <meta name="DC.Contributor" content="Christopher Carlsten"/>
  <meta name="DC.Contributor" content="Louise Organ"/>
  <meta name="DC.Contributor" content="Chitra Joseph"/>
  <meta name="DC.Contributor" content="Alison John"/>
  <meta name="DC.Contributor" content="Paul J Hanson"/>
  <meta name="DC.Contributor" content="Bruce M McManus"/>
  <meta name="DC.Contributor" content="Gisli Jenkins"/>
  <meta name="DC.Contributor" content="Karen Mossman"/>
  <meta name="DC.Contributor" content="Kjetil Ask"/>
  <meta name="DC.Contributor" content="Andrew C Doxey"/>
  <meta name="DC.Contributor" content="Jeremy A Hirota"/>
  <meta name="article:published_time" content="2020-04-12"/>
  <meta name="article:section" content="New Results"/>
  <meta name="citation_title" content="Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue"/>
  <meta name="citation_abstract" lang="en" content="&lt;;p&gt;;In December 2019, SARS-CoV-2 emerged causing the COVID-19 pandemic. SARS-CoV, the agent responsible for the 2003 SARS outbreak, utilizes ACE2 and TMPRSS2 host molecules for viral entry. ACE2 and TMPRSS2 have recently been implicated in SARS-CoV-2 viral infection. Additional host molecules including ADAM17, cathepsin L, CD147, and GRP78 may also function as receptors for SARS-CoV-2. To determine the expression and in situ localization of candidate SARS-CoV-2 receptors in the respiratory mucosa, we analyzed gene expression datasets from airway epithelial cells of 515 healthy subjects, gene promoter activity analysis using the FANTOM5 dataset containing 120 distinct sample types, single cell RNA sequencing (scRNAseq) of 10 healthy subjects, immunoblots on multiple airway epithelial cell types, and immunohistochemistry on 98 human lung samples. We demonstrate absent to low ACE2 promoter activity in a variety of lung epithelial cell samples and low ACE2 gene expression in both microarray and scRNAseq datasets of epithelial cell populations. Consistent with gene expression, rare ACE2 protein expression was observed in the airway epithelium and alveoli of human lung. We present confirmatory evidence for the presence of TMPRSS2, CD147, and GRP78 protein in vitro in airway epithelial cells and confirm broad in situ protein expression of CD147 in the respiratory mucosa. Collectively, our data suggest the presence of a mechanism dynamically regulating ACE2 expression in human lung, perhaps in periods of SARS-CoV-2 infection, and also suggest that alternate receptors for SARS-CoV-2 exist to facilitate initial host cell infection.&lt;;/p&gt;;"/>
  <meta name="citation_journal_title" content="bioRxiv"/>
  <meta name="citation_publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="citation_publication_date" content="2020/01/01"/>
  <meta name="citation_mjid" content="biorxiv;2020.04.07.030742v2"/>
  <meta name="citation_id" content="2020.04.07.030742v2"/>
  <meta name="citation_public_url" content="https://www.biorxiv.org/content/10.1101/2020.04.07.030742v2"/>
  <meta name="citation_abstract_html_url" content="https://www.biorxiv.org/content/10.1101/2020.04.07.030742v2.abstract"/>
  <meta name="citation_full_html_url" content="https://www.biorxiv.org/content/10.1101/2020.04.07.030742v2.full"/>
  <meta name="citation_pdf_url" content="https://www.biorxiv.org/content/biorxiv/early/2020/04/12/2020.04.07.030742.full.pdf"/>
  <meta name="citation_doi" content="10.1101/2020.04.07.030742"/>
  <meta name="citation_section" content="New Results"/>
  <meta name="citation_firstpage" content="2020.04.07.030742"/>
  <meta name="citation_author" content="Jennifer A Aguiar"/>
  <meta name="citation_author_institution" content="University of Waterloo;"/>
  <meta name="citation_author_email" content="jaaguiar@edu.uwaterloo.ca"/>
  <meta name="citation_author" content="Benjamin Jean-Marie Tremblay"/>
  <meta name="citation_author_institution" content="University of Waterloo;"/>
  <meta name="citation_author_email" content="benjmtremblay@gmail.com"/>
  <meta name="citation_author" content="Michael J Mansfield"/>
  <meta name="citation_author_institution" content="Okinawa Institute of Science and Technology;"/>
  <meta name="citation_author_email" content="mansfield550@gmail.com"/>
  <meta name="citation_author" content="Owen Woody"/>
  <meta name="citation_author_institution" content="University of Waterloo;"/>
  <meta name="citation_author_email" content="owoody@uwaterloo.ca"/>
  <meta name="citation_author" content="Briallen Lobb"/>
  <meta name="citation_author_institution" content="University of Waterloo;"/>
  <meta name="citation_author_email" content="balobb@uwaterloo.ca"/>
  <meta name="citation_author" content="Arinjay Banerjee"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="banera9@mcmaster.ca"/>
  <meta name="citation_author" content="Abiram Chandiramohan"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="chanda15@mcmaster.ca"/>
  <meta name="citation_author" content="Nicholas Tiessen"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="tiessenn@mcmaster.ca"/>
  <meta name="citation_author" content="Anna Dvorkin-Gheva"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="dvorkin@mcmaster.ca"/>
  <meta name="citation_author" content="Spencer Revill"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="revillsd@mcmaster.ca"/>
  <meta name="citation_author" content="Matthew S Miller"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="mmiller@mcmaster.ca"/>
  <meta name="citation_author" content="Christopher Carlsten"/>
  <meta name="citation_author_institution" content="University of British Columbia;"/>
  <meta name="citation_author_email" content="carlsten@mail.ubc.ca"/>
  <meta name="citation_author" content="Louise Organ"/>
  <meta name="citation_author_institution" content="The University of Nottingham"/>
  <meta name="citation_author_email" content="louise.organ@nottingham.ac.uk"/>
  <meta name="citation_author" content="Chitra Joseph"/>
  <meta name="citation_author_institution" content="The University of Nottingham"/>
  <meta name="citation_author_email" content="chitra.joseph@nottingham.ac.uk"/>
  <meta name="citation_author" content="Alison John"/>
  <meta name="citation_author_institution" content="The University of Nottingham"/>
  <meta name="citation_author_email" content="alison.john@nottingham.ac.uk"/>
  <meta name="citation_author" content="Paul J Hanson"/>
  <meta name="citation_author_institution" content="University of British Columbia;"/>
  <meta name="citation_author_email" content="paul.hanson@hli.ubc.ca"/>
  <meta name="citation_author" content="Bruce M McManus"/>
  <meta name="citation_author_institution" content="University of British Columbia;"/>
  <meta name="citation_author_email" content="bruce.mcmanus@hli.ubc.ca"/>
  <meta name="citation_author" content="Gisli Jenkins"/>
  <meta name="citation_author_institution" content="The University of Nottingham"/>
  <meta name="citation_author_email" content="gisli.jenkins@nottingham.ac.uk"/>
  <meta name="citation_author" content="Karen Mossman"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="mossk@mcmaster.ca"/>
  <meta name="citation_author" content="Kjetil Ask"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="askkj@mcmaster.ca"/>
  <meta name="citation_author_orcid" content="http://orcid.org/0000-0002-0202-735X"/>
  <meta name="citation_author" content="Andrew C Doxey"/>
  <meta name="citation_author_institution" content="University of Waterloo;"/>
  <meta name="citation_author_email" content="acdoxey@uwaterloo.ca"/>
  <meta name="citation_author" content="Jeremy A Hirota"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="hirotaja@mcmaster.ca"/>
  <meta name="twitter:title" content="Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue"/>
  <meta name="twitter:site" content="@biorxivpreprint"/>
  <meta name="twitter:card" content="summary"/>
  <meta name="twitter:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="twitter:description" content="In December 2019, SARS-CoV-2 emerged causing the COVID-19 pandemic. SARS-CoV, the agent responsible for the 2003 SARS outbreak, utilizes ACE2 and TMPRSS2 host molecules for viral entry. ACE2 and TMPRSS2 have recently been implicated in SARS-CoV-2 viral infection. Additional host molecules including ADAM17, cathepsin L, CD147, and GRP78 may also function as receptors for SARS-CoV-2. To determine the expression and in situ localization of candidate SARS-CoV-2 receptors in the respiratory mucosa, we analyzed gene expression datasets from airway epithelial cells of 515 healthy subjects, gene promoter activity analysis using the FANTOM5 dataset containing 120 distinct sample types, single cell RNA sequencing (scRNAseq) of 10 healthy subjects, immunoblots on multiple airway epithelial cell types, and immunohistochemistry on 98 human lung samples. We demonstrate absent to low ACE2 promoter activity in a variety of lung epithelial cell samples and low ACE2 gene expression in both microarray and scRNAseq datasets of epithelial cell populations. Consistent with gene expression, rare ACE2 protein expression was observed in the airway epithelium and alveoli of human lung. We present confirmatory evidence for the presence of TMPRSS2, CD147, and GRP78 protein in vitro in airway epithelial cells and confirm broad in situ protein expression of CD147 in the respiratory mucosa. Collectively, our data suggest the presence of a mechanism dynamically regulating ACE2 expression in human lung, perhaps in periods of SARS-CoV-2 infection, and also suggest that alternate receptors for SARS-CoV-2 exist to facilitate initial host cell infection. ### Competing Interest Statement The authors have declared no competing interest."/>
  <meta name="og-title" property="og:title" content="Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue"/>
  <meta name="og-url" property="og:url" content="https://www.biorxiv.org/content/10.1101/2020.04.07.030742v2"/>
  <meta name="og-site-name" property="og:site_name" content="bioRxiv"/>
  <meta name="og-description" property="og:description" content="In December 2019, SARS-CoV-2 emerged causing the COVID-19 pandemic. SARS-CoV, the agent responsible for the 2003 SARS outbreak, utilizes ACE2 and TMPRSS2 host molecules for viral entry. ACE2 and TMPRSS2 have recently been implicated in SARS-CoV-2 viral infection. Additional host molecules including ADAM17, cathepsin L, CD147, and GRP78 may also function as receptors for SARS-CoV-2. To determine the expression and in situ localization of candidate SARS-CoV-2 receptors in the respiratory mucosa, we analyzed gene expression datasets from airway epithelial cells of 515 healthy subjects, gene promoter activity analysis using the FANTOM5 dataset containing 120 distinct sample types, single cell RNA sequencing (scRNAseq) of 10 healthy subjects, immunoblots on multiple airway epithelial cell types, and immunohistochemistry on 98 human lung samples. We demonstrate absent to low ACE2 promoter activity in a variety of lung epithelial cell samples and low ACE2 gene expression in both microarray and scRNAseq datasets of epithelial cell populations. Consistent with gene expression, rare ACE2 protein expression was observed in the airway epithelium and alveoli of human lung. We present confirmatory evidence for the presence of TMPRSS2, CD147, and GRP78 protein in vitro in airway epithelial cells and confirm broad in situ protein expression of CD147 in the respiratory mucosa. Collectively, our data suggest the presence of a mechanism dynamically regulating ACE2 expression in human lung, perhaps in periods of SARS-CoV-2 infection, and also suggest that alternate receptors for SARS-CoV-2 exist to facilitate initial host cell infection. ### Competing Interest Statement The authors have declared no competing interest."/>
  <meta name="og-type" property="og:type" content="article"/>
  <meta name="og-image" property="og:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="citation_date" content="2020-04-12"/> 
  <meta name="description" content="bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution"/>
  <meta name="generator" content="Drupal 7 (http://drupal.org)"/> 
  <title>Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue | bioRxiv</title> 
 </head>
 <body class="html not-front not-logged-in page-node page-node- page-node-1240392 node-type-highwire-article context-content hw-default-jcode-biorxiv hw-article-category-new-results"> 
  <div class="article abstract-view ">
   <span class="highwire-journal-article-marker-start"/>
   <div class="section abstract" id="abstract-1">
    <h2>Abstract</h2>
    <p id="p-2">In December 2019, SARS-CoV-2 emerged causing the COVID-19 pandemic. SARS-CoV, the agent responsible for the 2003 SARS outbreak, utilizes ACE2 and TMPRSS2 host molecules for viral entry. ACE2 and TMPRSS2 have recently been implicated in SARS-CoV-2 viral infection. Additional host molecules including ADAM17, cathepsin L, CD147, and GRP78 may also function as receptors for SARS-CoV-2. To determine the expression and in situ localization of candidate SARS-CoV-2 receptors in the respiratory mucosa, we analyzed gene expression datasets from airway epithelial cells of 515 healthy subjects, gene promoter activity analysis using the FANTOM5 dataset containing 120 distinct sample types, single cell RNA sequencing (scRNAseq) of 10 healthy subjects, immunoblots on multiple airway epithelial cell types, and immunohistochemistry on 98 human lung samples. We demonstrate absent to low ACE2 promoter activity in a variety of lung epithelial cell samples and low ACE2 gene expression in both microarray and scRNAseq datasets of epithelial cell populations. Consistent with gene expression, rare ACE2 protein expression was observed in the airway epithelium and alveoli of human lung. We present confirmatory evidence for the presence of TMPRSS2, CD147, and GRP78 protein in vitro in airway epithelial cells and confirm broad in situ protein expression of CD147 in the respiratory mucosa. Collectively, our data suggest the presence of a mechanism dynamically regulating ACE2 expression in human lung, perhaps in periods of SARS-CoV-2 infection, and also suggest that alternate receptors for SARS-CoV-2 exist to facilitate initial host cell infection.</p>
   </div>
   <h3>Competing Interest Statement</h3>
   <p id="p-3">The authors have declared no competing interest.</p>
   <div class="section fn-group" id="fn-group-1">
    <h2>Footnotes</h2>
    <ul>
     <li class="fn-update fn-group-summary-of-updates" id="fn-1">
      <p id="p-4">This is the final version submitted for peer-review (European Respiratory Journal - ERJ). The version is double spaced as per ERJ submission guidelines. The final version now includes supplementary immunohistochemistry of human lung tissue microvasculature and human heart for positive ACE2 staining (previous version did not include this data). Paul Hanson and Bruce McManus were added as authors as they provided the human heart tissue for the ACE2 staining. A cartoon schematic was also added as a Figure 6 to summarize the characterization of the molecules. </p>
     </li>
    </ul>
   </div>
   <span class="highwire-journal-article-marker-end"/>
  </div>
 </body>
</html>
